TipRanks
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
Japanese Market
4577
Daito Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4577 full AI Analyst Report?

Daito Pharmaceutical Co., Ltd. (4577) Ratios

0 Followers

Daito Pharmaceutical Co., Ltd. Ratios

JP:4577's free cash flow for Q4 2025 was ¥0.20. For the 2025 fiscal year, JP:4577's free cash flow was decreased by ¥ and operating cash flow was ¥0.06. See a summary of the company’s cash flow.
Ratios
TTM
May 25May 24May 23May 22
Liquidity Ratios
Current Ratio
 2.62 2.62 2.45 2.24 2.64
Quick Ratio
 1.44 1.44 1.37 1.11 1.45
Cash Ratio
 0.07 0.07 0.13 0.15 0.23
Solvency Ratio
 0.31 0.37 0.24 0.27 0.38
Operating Cash Flow Ratio
 0.67 0.67 0.35 0.28 0.27
Short-Term Operating Cash Flow Coverage
 2.82 2.82 1.90 2.47 2.77
Net Current Asset Value
¥ 16.28B¥ 16.28B¥ 15.78B¥ 16.02B¥ 21.08B
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.13 0.15 0.11 0.07
Debt-to-Equity Ratio
 0.18 0.18 0.23 0.17 0.10
Debt-to-Capital Ratio
 0.15 0.15 0.19 0.14 0.09
Long-Term Debt-to-Capital Ratio
 0.07 0.07 0.11 0.08 0.06
Financial Leverage Ratio
 1.39 1.39 1.50 1.49 1.39
Debt Service Coverage Ratio
 1.90 2.06 1.93 3.21 4.91
Interest Coverage Ratio
 27.98 27.98 21.31 94.98 433.92
Debt to Market Cap
 0.19 0.21 0.32 0.39 0.29
Interest Debt Per Share
 326.16 320.38 394.73 558.28 314.26
Net Debt to EBITDA
 1.11 1.04 1.31 0.76 0.15
Profitability Margins
Gross Profit Margin
19.54%19.54%16.73%20.98%22.91%
EBIT Margin
8.39%7.18%6.08%9.08%11.28%
EBITDA Margin
14.79%15.84%14.64%16.89%19.86%
Operating Profit Margin
7.18%7.18%5.18%8.30%11.55%
Pretax Profit Margin
8.03%8.03%5.84%8.99%11.25%
Net Profit Margin
6.24%6.24%3.77%7.03%7.98%
Continuous Operations Profit Margin
6.19%6.19%3.49%6.78%7.82%
Net Income Per EBT
77.76%77.76%64.50%78.12%70.92%
EBT Per EBIT
111.77%111.77%112.86%108.32%97.48%
Return on Assets (ROA)
4.31%4.31%2.45%4.24%5.10%
Return on Equity (ROE)
6.04%5.98%3.67%6.33%7.10%
Return on Capital Employed (ROCE)
6.13%6.13%4.30%6.58%9.45%
Return on Invested Capital (ROIC)
4.48%4.48%2.43%4.76%6.39%
Return on Tangible Assets
4.42%4.42%2.46%4.27%5.13%
Earnings Yield
8.26%9.24%6.37%18.87%21.75%
Efficiency Ratios
Receivables Turnover
 2.67 2.67 2.50 3.04 2.55
Payables Turnover
 5.49 5.49 5.10 4.26 7.84
Inventory Turnover
 2.48 2.48 2.29 1.77 1.91
Fixed Asset Turnover
 1.65 1.65 1.59 1.47 1.75
Asset Turnover
 0.69 0.69 0.65 0.60 0.64
Working Capital Turnover Ratio
 2.22 2.14 2.13 1.95 1.84
Cash Conversion Cycle
 217.40 217.40 233.80 240.26 287.77
Days of Sales Outstanding
 136.60 136.60 145.98 120.18 142.87
Days of Inventory Outstanding
 147.23 147.23 159.37 205.77 191.45
Days of Payables Outstanding
 66.43 66.43 71.55 85.68 46.56
Operating Cycle
 283.83 283.83 305.34 325.95 334.33
Cash Flow Ratios
Operating Cash Flow Per Share
 324.53 318.79 193.85 330.25 262.73
Free Cash Flow Per Share
 191.32 187.93 -31.46 -69.72 -88.59
CapEx Per Share
 133.21 130.85 225.30 399.97 351.32
Free Cash Flow to Operating Cash Flow
 0.59 0.59 -0.16 -0.21 -0.34
Dividend Paid and CapEx Coverage Ratio
 1.89 1.89 0.75 0.72 0.64
Capital Expenditure Coverage Ratio
 2.44 2.44 0.86 0.83 0.75
Operating Cash Flow Coverage Ratio
 1.01 1.01 0.50 0.59 0.84
Operating Cash Flow to Sales Ratio
 0.19 0.19 0.12 0.11 0.09
Free Cash Flow Yield
14.53%16.16%-3.19%-6.26%-8.46%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.28 10.82 15.70 5.30 4.60
Price-to-Sales (P/S) Ratio
 0.75 0.68 0.59 0.37 0.37
Price-to-Book (P/B) Ratio
 0.72 0.65 0.58 0.34 0.33
Price-to-Free Cash Flow (P/FCF) Ratio
 6.86 6.19 -31.31 -15.96 -11.82
Price-to-Operating Cash Flow Ratio
 4.07 3.65 5.08 3.37 3.98
Price-to-Earnings Growth (PEG) Ratio
 0.17 0.15 -0.39 -0.68 -0.18
Price-to-Fair Value
 0.72 0.65 0.58 0.34 0.33
Enterprise Value Multiple
 6.18 5.30 5.35 2.96 2.00
Enterprise Value
 46.40B 42.55B 39.64B 23.46B 17.91B
EV to EBITDA
 6.19 5.30 5.35 2.96 2.00
EV to Sales
 0.92 0.84 0.78 0.50 0.40
EV to Free Cash Flow
 8.39 7.70 -41.42 -21.44 -12.78
EV to Operating Cash Flow
 4.95 4.54 6.72 4.53 4.31
Tangible Book Value Per Share
 1.77K 1.74K 1.69K 3.30K 3.20K
Shareholders’ Equity Per Share
 1.83K 1.80K 1.71K 3.32K 3.20K
Tax and Other Ratios
Effective Tax Rate
 0.23 0.23 0.40 0.25 0.31
Revenue Per Share
 1.75K 1.72K 1.66K 2.99K 2.85K
Net Income Per Share
 109.40 107.46 62.72 209.99 227.64
Tax Burden
 0.78 0.78 0.65 0.78 0.71
Interest Burden
 0.96 1.12 0.96 0.99 1.00
Research & Development to Revenue
 0.00 0.00 0.05 0.05 0.04
SG&A to Revenue
 0.12 0.12 0.07 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 2.97 2.97 3.09 1.23 0.82
Currency in JPY